Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XSU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. The delivery order, which expires September 11, 2025, covers 60 tablets of Xtandi 80 mg, an oncology medication used to treat advanced prostate cancer. This award was issued without a set-aside designation, demonstrating the company's competitive positioning in federal pharmaceutical procurement despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which carries a ceiling value of $499,999,999 and extends through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established track record as a critical supplier in the federal pharmaceutical supply chain, combined with its nearly two decades of SAM.gov registration, positions the company as a key distributor of specialty medications and pharmacy services to military health systems.
Quick answers
Who was awarded contract SPE2DX25F6XSU?
SPE2DX25F6XSU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 10, 2025.
How much is contract SPE2DX25F6XSU worth?
The government has obligated $8,339 on SPE2DX25F6XSU.
Is contract SPE2DX25F6XSU an order under another contract?
Yes. SPE2DX25F6XSU is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XSU competed?
The extent of competition for SPE2DX25F6XSU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award